How Vaccine Injury Compensation Works in the United States (VICP Explained)
Learn how vaccine injury compensation works in the United States, including vaccine court, VICP claims, compensation types, and how vaccine injuries are proven through federal litigation.
Most Americans do not realize that the United States has a special legal system designed specifically to compensate individuals injured by vaccines.
This system is called the National Vaccine Injury Compensation Program (VICP)—often referred to as “vaccine court.”
Congress created the program in the 1980s after concerns arose that lawsuits against vaccine manufacturers could threaten the stability of the national vaccine supply. The result was a system designed to balance two important goals:
Protect the public by maintaining a stable vaccine supply, and
Provide compensation to individuals who suffer rare vaccine-related injuries.
Today, the Vaccine Injury Compensation Program (VICP) remains the primary legal pathway for resolving vaccine injury claims in the United States.
The Law That Created Vaccine Court
The Vaccine Injury Compensation Program was created by the National Childhood Vaccine Injury Act of 1986, which amended the Public Health Service Act and established a new framework for resolving vaccine injury claims in the United States.
The statute establishing the program can be found here:
National Childhood Vaccine Injury Act (Public Health Service Act §§ 300aa-1 through 300aa-34) https://www.hrsa.gov/sites/default/files/hrsa/vicp/title-xxi-phs-vaccines-1517.pdf
Congress enacted the Vaccine Act during a period of growing litigation against vaccine manufacturers in the early 1980s. Large product liability verdicts, particularly involving the DPT vaccine, created significant uncertainty in the vaccine market. Several manufacturers considered leaving the market altogether, raising concerns that the nation’s vaccine supply—and routine childhood immunization programs—could be jeopardized.
The Vaccine Act was designed to solve two problems at once. First, it created a remedial vaccine injury compensation program for individuals who experience rare but serious vaccine injuries. Second, it provided liability protections for vaccine manufacturers and administrators to help ensure that vaccines remained widely available.
Under this framework, individuals who believe they were injured by a covered vaccine may file a petition in the National Vaccine Injury Compensation Program (VICP) rather than pursuing traditional civil litigation. The program operates as a no-fault vaccine injury compensation system, meaning petitioners do not need to prove negligence, product defect, or wrongdoing by a manufacturer. Instead, the central question is whether the vaccine caused or contributed to the injury.
Congress intentionally established a lower evidentiary burden than traditional civil courts to help ensure that individuals with plausible vaccine injury claims could receive compensation more efficiently. The goal was not to determine whether vaccines are generally safe or unsafe, nor to serve as a forum for resolving broader scientific debates about vaccine safety.
Rather, the VICP was created as a remedial compensation system—one designed to provide relatively quick and generous compensation when causation can be established, while preserving public confidence in vaccination programs.
The tradeoff created by the Vaccine Act was clear: in exchange for reduced litigation risk, vaccine manufacturers and administrators agreed to participate in a system where individuals injured by recommended vaccines could seek compensation through a specialized legal process. Vaccines recommended for routine use in children are therefore generally covered by the program.
This framework reflects an important public health principle: vaccination benefits society as a whole, but when rare injuries occur, those individuals should not bear the cost alone.
What Is the Vaccine Injury Compensation Program?
The Vaccine Injury Compensation Program (VICP) is a federal program that resolves vaccine injury claims through a specialized legal process administered by the U.S. Court of Federal Claims.
Rather than being handled in traditional civil courts, vaccine injury cases are heard by judicial officers known as Special Masters within the court’s Office of Special Masters.
These officials focus exclusively on vaccine injury litigation and routinely evaluate complex medical records, expert testimony, and scientific evidence.
The program is funded through a federal excise tax on each covered vaccine dose, which is deposited into the Vaccine Injury Compensation Trust Fund. This funding mechanism means that compensation awards do not come from general taxpayer revenue but from the vaccine program itself.
Several government entities participate in the Vaccine Injury Compensation Program and play distinct roles in the adjudication process.
Petitioner
The injured individual—or, in cases involving minors or deceased individuals, a parent, guardian, or estate representative—who files the vaccine injury claim.
Petitioners are typically represented by attorneys experienced in Vaccine Act litigation. Many of these attorneys are members of the Vaccine Injured Petitioners Bar Association, a professional organization composed of lawyers who regularly represent petitioners in vaccine court proceedings.
Department of Health and Human Services (HHS)
The Department of Health and Human Services administers the Vaccine Injury Compensation Program and conducts the initial medical review of each petition. Medical experts within HHS evaluate the petitioner’s medical records and scientific evidence to determine whether the government will concede that the vaccine caused the injury or contest the claim. HHS also maintains and updates the Vaccine Injury Table, which lists injuries that are presumed to be caused by certain vaccines if they occur within specified time frames. The department determines which vaccines are covered under the program and which injuries qualify for table presumptions. For example, HHS has thus far declined to add COVID-19 vaccines to the Vaccine Injury Table, meaning those injuries currently fall outside the VICP and instead are addressed through a different federal compensation program.
Department of Justice (DOJ)
Attorneys from the Department of Justice represent the Secretary of Health and Human Services in vaccine court proceedings. In this role, DOJ attorneys serve as the legal adversaries to petitioners’ counsel. They evaluate the medical evidence, negotiate settlements when appropriate, and litigate contested claims before the Office of Special Masters. The DOJ is also responsible for processing compensation awards once a case is resolved.
Special Masters
Special Masters are the judicial officers who preside over vaccine injury cases and ultimately determine whether compensation should be awarded. They are not traditional federal or state judges; rather, they are appointed by the U.S. Court of Federal Claims to serve renewable four-year terms. Special Masters conduct hearings, review expert reports, evaluate medical records, and issue written decisions resolving vaccine injury claims. Their decisions can be appealed to judges of the U.S. Court of Federal Claims, who serve as the appellate authority within the vaccine program. Unlike traditional civil litigation, vaccine injury claims are decided without a jury, and the proceedings are designed to focus heavily on medical evidence and expert testimony.
Together, these participants form the structure of the Vaccine Injury Compensation Program, a system intended to provide a specialized forum for resolving vaccine injury claims while maintaining the stability of the national vaccination program.
What Counts as a Vaccine Injury?
Table Injuries
Within the Vaccine Injury Compensation Program, some injuries are recognized on what is known as the Vaccine Injury Table. These are injuries for which the scientific evidence linking a specific vaccine to a specific condition is strong enough that the government has made a policy determination to presume causation when certain criteria are met.
In practical terms, a Table injury exists when three elements are satisfied:
A covered vaccine was administered.
The petitioner developed a specific injury listed on the Vaccine Injury Table.
The symptoms began within a defined time period after vaccination.
When these criteria are met, the law presumes that the vaccine caused the injury, unless the government can demonstrate that another factor caused the condition. This presumption significantly reduces the evidentiary burden placed on petitioners.
A commonly cited example involves Guillain-Barré Syndrome (GBS). GBS is recognized as a Table injury only in connection with the influenza vaccine, and only when the onset of symptoms occurs between 3 and 42 days after vaccination. If those conditions are satisfied, causation is presumed.
Although the Vaccine Injury Table exists to simplify certain claims, it is relatively limited in scope. Only a small number of injuries currently qualify for the presumption of causation, and in practice two of the most frequently litigated Table injury claims are:
• Shoulder Injury Related to Vaccine Administration (SIRVA)
• Guillain-Barré Syndrome following influenza vaccination
Because these cases involve injuries that have already been recognized by the Vaccine Injury Table, they are typically handled through a specialized division of vaccine court known as the Special Processing Unit (SPU). The SPU operates under the direction of the Chief Special Master and a team of staff attorneys who focus on resolving these cases more efficiently, often through streamlined proceedings and settlements.
Off-Table Injuries (Causation-in-Fact)
While Table injuries receive the most public attention, the majority of vaccine injury cases are actually off-table claims.
An off-table injury is any condition that does not appear on the Vaccine Injury Table. In these cases, petitioners must prove that the vaccine caused their injury through a legal framework known as causation-in-fact.
These cases are typically assigned to the remaining Special Masters within the Office of Special Masters and are evaluated under the legal standard established by the Federal Circuit in Althen v. Secretary of Health and Human Services.
Under Althen, petitioners must establish three elements to prove causation:
1. A medically plausible theory of causation
The petitioner must present a scientifically credible explanation for how the vaccine could cause the type of injury alleged. This does not require definitive scientific proof but must be grounded in sound medical reasoning.
2. A logical sequence of cause and effect
The petitioner must show that the facts of the case support the theory that the vaccine caused the injury in that specific individual. This often involves medical records documenting symptoms, physician observations, and expert testimony connecting the theory to the patient’s clinical course.
3. A proximate temporal relationship between vaccination and injury
The onset of symptoms must occur within a timeframe that is medically consistent with the proposed mechanism of injury. Timing alone is not enough to prove causation, but an appropriate temporal relationship is a necessary component of the analysis.
Together, these three elements form the foundation of causation-in-fact analysis in vaccine court.
Off-Table Vaccine Injuries
Off-table cases often involve complex neurological, autoimmune, or inflammatory conditions where medical experts must explain how an immune response triggered by vaccination could lead to the injury.
Some of the more commonly litigated off-table claims include:
Neurological and demyelinating disorders
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Guillain-Barré Syndrome variants (AIDP, AMAN, AMSAN)
• Transverse Myelitis
• Acute Disseminated Encephalomyelitis (ADEM)
• Neuromyelitis Optica
• MOG Antibody Disease (MOGAD)
• Optic Neuritis
• Encephalitis
Peripheral nerve and autonomic disorders
• Small Fiber Neuropathy (SFN)
• Postural Orthostatic Tachycardia Syndrome (POTS)
• Acute Panautonomic Neuropathy
• Parsonage-Turner Syndrome (Brachial Neuritis)
• Polyneuritis Cranialis
Autoimmune and inflammatory disorders
• Myasthenia Gravis
• Dermatomyositis
• Autoimmune Hepatitis
• Autoimmune Hemolytic Anemia
• Aplastic Anemia
• Granulomatosis with Polyangiitis
• Polyarteritis Nodosa
• Henoch-Schönlein Purpura
• Vasculitis
Other immune-mediated conditions
• Immune Thrombocytopenia (ITP)
• Narcolepsy
• Uveitis
• Pemphigus
• Linear IgA Bullous Dermatosis
• Complex Regional Pain Syndrome (CRPS)
These cases frequently require detailed medical expert reports and scientific literature to explain the potential immune-mediated mechanisms linking vaccination to the injury.
Why the Distinction Matters
The distinction between Table injuries and off-table causation-in-fact cases reflects the structure Congress created when it enacted the Vaccine Act.
Table injuries allow the program to quickly compensate individuals with well-recognized vaccine reactions, while off-table cases ensure that individuals with less commonly recognized conditions still have an opportunity to establish causation through medical evidence.
Together, these two pathways allow the Vaccine Injury Compensation Program to function as a remedial compensation system that addresses plausible vaccine injuries while maintaining the stability of the national vaccination program.
What Are the Most Common Vaccine Injuries?
Vaccines are among the most carefully studied medical products in modern medicine and remain overwhelmingly safe. However, as Congress recognized when it enacted the Vaccine Act, rare adverse reactions can occur. These reactions form the basis of vaccine injury claims brought in the Vaccine Injury Compensation Program.
Among the most commonly litigated vaccine injury claims are Shoulder Injury Related to Vaccine Administration (SIRVA) and Guillain-Barré Syndrome (GBS) following influenza vaccination. SIRVA occurs when a vaccine is administered too high in the shoulder joint, causing inflammation or injury to structures such as the bursa, rotator cuff tendons, or surrounding tissues. Guillain-Barré Syndrome is a neurological disorder in which the immune system attacks peripheral nerves, potentially leading to weakness, paralysis, and other neurological complications.
Many vaccine injury claims are also brought as off-table injuries, meaning the condition does not appear on the Vaccine Injury Table and causation must be proven through medical evidence and expert testimony. Some of the most frequently litigated off-table vaccine injury claims include immune thrombocytopenia (ITP), chronic inflammatory demyelinating polyneuropathy (CIDP), transverse myelitis (TM), acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), and brachial neuritis (Parsonage-Turner syndrome).
These cases often involve complex neurological or immune-mediated mechanisms and typically require expert testimony explaining how an immune response triggered by vaccination could plausibly lead to the injury.
How Vaccine Injury Claims Are Proven
Vaccine injury claims are decided using a legal standard known as preponderance of the evidence. This standard is lower than the burden typically required in traditional civil litigation and reflects Congress’s intent that the Vaccine Injury Compensation Program function as a remedial compensation system rather than a fault-based lawsuit.
Under this standard, the petitioner must demonstrate that it is more likely than not that the vaccine caused or significantly contributed to the injury. Petitioners are not required to prove causation with absolute scientific certainty or establish negligence by a vaccine manufacturer or administrator. Instead, the Special Master evaluates whether the totality of the evidence supports a plausible causal relationship between the vaccination and the injury.
Evidence in vaccine injury cases usually includes:
• medical records, including vaccination documentation and records showing the onset and progression of symptoms
• witness affidavits, often from the petitioner or family members describing the timing and development of symptoms
• treating physician opinions, which may document early suspicion of a vaccine-related injury
• expert medical reports from qualified specialists such as neurologists, rheumatologists, orthopedic surgeons, and immunologists
• scientific and medical literature discussing potential biological mechanisms linking vaccination to the injury
• temporal evidence, showing that symptoms began within a medically reasonable timeframe after vaccination
Special Masters review all submitted evidence—including expert testimony, medical literature, and factual records—to determine whether the petitioner has established a logical and medically plausible causal connection between the vaccine and the injury.
What Compensation Can Be Awarded?
If a petitioner successfully proves a vaccine injury claim, the Vaccine Injury Compensation Program (VICP) may award several categories of compensation designed to address both the economic and non-economic impact of the injury. The purpose of the program is to place the injured individual as close as possible to the financial position they would have been in had the injury not occurred.
1. Past and Future Medical Expenses
The program may reimburse medical expenses related to the vaccine injury that were not covered by health insurance. This can include hospitalizations, physician visits, surgeries, rehabilitation services, medications, diagnostic testing, assistive devices, and other treatment-related costs necessary to manage the injury both now and in the future.
2. Lost Wages and Loss of Earning Capacity
Petitioners may receive compensation for income lost as a result of the injury. This includes both past wages lost while the injured individual was unable to work and future income losses if the injury limits the individual’s ability to return to their previous occupation or maintain full-time employment.
3. Pain and Suffering
The program allows compensation for pain and suffering, which includes physical pain, emotional distress, and diminished quality of life resulting from the injury. Under the Vaccine Act, these damages are capped at $250,000.
4. Future Care Costs
In cases involving permanent or long-term injuries, compensation may include funding for future medical care and life-care needs. These damages are often calculated using detailed life-care plans prepared by medical or nursing experts that outline expected future treatments, therapies, medications, and supportive services.
5. Death Benefit
If a vaccine injury results in death, the program may award a death benefit to surviving family members.
6. Attorney’s Fees and Costs
The Vaccine Act also allows attorney’s fees and litigation costs to be paid separately by the program, provided the claim was filed in good faith and supported by a reasonable basis. This provision ensures that individuals can pursue legitimate claims without bearing the financial burden of legal representation.
How Long Vaccine Injury Cases Take
The timeline for resolving a vaccine injury claim varies significantly depending on the complexity of the case, the type of injury alleged, and whether the government concedes or contests causation. While some claims resolve relatively quickly through settlement, others—particularly complex neurological or autoimmune cases—can take several years to reach a final decision.
The process generally unfolds in several stages.
1. Medical Treatment and Documentation of the Injury
Before a case can be filed, the injured individual must typically experience symptoms of the alleged vaccine injury for at least six months. This requirement is part of the Vaccine Act’s statutory severity requirement, which ensures that only injuries causing significant or lasting harm are eligible for compensation. An exception exists when the injury results in surgery requiring hospitalization, in which case a claim may be filed sooner.
2. Collection of Medical Records
Prior to filing the claim, attorneys must obtain and review extensive medical records documenting the petitioner’s medical history, vaccination records, and treatment following the injury. These records often include years of pre-vaccination medical history, vaccination documentation, diagnostic testing, physician notes, and specialist evaluations.
3. Filing the Petition in the U.S. Court of Federal Claims
Once the records have been collected and reviewed, a petition is filed with the U.S. Court of Federal Claims, initiating the case within the Vaccine Injury Compensation Program.
4. Court Review of the Petition and Medical Records
After filing, the court conducts an initial review to ensure that the petition and supporting medical records are complete and sufficient to begin litigation. If additional documentation is required, the court may order the petitioner to supplement the record.
5. Review by the Department of Health and Human Services (HHS)
The medical records are then reviewed by physicians and legal staff within the Department of Health and Human Services (HHS). HHS evaluates the evidence and determines its preliminary position on the case. At this stage, the government may:
Concede causation, acknowledging that the vaccine caused the injury;
Enter settlement discussions, even if causation is disputed; or
Contest the merits of the claim.
6. Damages Negotiations or Settlement Discussions
If HHS concedes causation, the case proceeds directly to damages negotiations, where the parties evaluate compensation for medical expenses, lost wages, pain and suffering, and future care needs. When cases settle, damages discussions follow a similar process, although the government may not formally concede causation.
7. Expert Reports in Contested Cases
If the government contests the claim, the case enters a more complex litigation phase. Both parties typically retain medical experts to analyze the medical records and relevant scientific literature. Expert reports in vaccine court cases are often detailed and extensive, addressing immunology, neurology, epidemiology, and other medical specialties. This phase can take a prolonged period of time due to the depth of analysis involved.
8. Briefing or Evidentiary Hearing
After expert reports are submitted, the case may proceed in one of several ways. The parties may reach a settlement after reviewing the expert evidence, or they may submit legal briefing on the causation issues for the Special Master to decide. In some cases, the Office of Special Masters may schedule a trial (evidentiary hearing) where experts testify and are cross-examined.
9. Decision by the Office of Special Masters
Once briefing is completed or a hearing has occurred, the Special Master issues a written decision on causation. Depending on the complexity of the case and the court’s docket, obtaining a final decision can take anywhere from six months to several years, with some contested cases taking three to four years or more before a final ruling is issued.
Because of these multiple stages—medical review, expert analysis, and legal briefing—the timeline for vaccine injury litigation can vary widely. However, the structure of the program is designed to ensure that claims are evaluated carefully and based on thorough medical and scientific evidence.
Why Civil Lawsuits for Vaccine Injuries Are Rare
Under the National Childhood Vaccine Injury Act of 1986, individuals who believe they were injured by a covered vaccine are generally required to first file a claim through the Vaccine Injury Compensation Program (VICP) before pursuing a traditional civil lawsuit. This requirement is often referred to as the “exhaustion” requirement, meaning a claimant must first attempt to resolve the claim through the Vaccine Program before filing a case in civil court.
The Vaccine Act also limits certain types of product liability claims against vaccine manufacturers, particularly claims based on allegations that a vaccine’s design is defective. These protections were intended to reduce the risk that extensive litigation or large jury verdicts could discourage manufacturers from producing vaccines or threaten the stability of the national vaccine supply.
Can you sue a vaccine manufacturer?
The scope of these protections was further clarified by the United States Supreme Court in Bruesewitz v. Wyeth (2011). In that case, the Court held that the Vaccine Act preempts most design defect claims against vaccine manufacturers for injuries caused by vaccines covered under the program. In practical terms, the decision significantly limits the ability of individuals to pursue civil lawsuits alleging that a vaccine should have been designed differently or made safer.
As a result of the Vaccine Act and the Bruesewitz decision, most vaccine injury claims must be pursued through the VICP rather than through traditional product liability litigation. Congress designed this structure to ensure that vaccine injury claims are evaluated within a specialized system capable of addressing complex medical and scientific evidence while still providing a pathway for compensation.
Why Vaccine Injury Compensation Matters
Vaccines have transformed modern medicine by dramatically reducing the spread of infectious diseases that once caused widespread illness and death. Routine vaccination programs protect not only the individuals receiving vaccines but also the broader community, particularly infants, elderly individuals, and people with compromised immune systems who may be more vulnerable to severe infections.
At the same time, Congress recognized that no medical intervention is completely without risk. Although serious vaccine injuries are rare, the Vaccine Act acknowledges that when such injuries occur, the individuals affected should not bear the consequences alone.
The Vaccine Injury Compensation Program was designed to uphold this principle by creating a system that compensates individuals who experience rare vaccine-related injuries while preserving the stability of the national vaccination program. By providing a fair, specialized, and more accessible compensation process, the VICP helps maintain public trust in vaccines and ensures that the small number of individuals injured by vaccines receive meaningful support.
How Many Vaccine Injury Claims Are Filed Each Year?
The number of vaccine injury claims filed each year varies depending on vaccination patterns, public awareness of the Vaccine Injury Compensation Program, and which vaccines are covered by the program. Since the program began operating in 1988, thousands of petitions have been filed in the U.S. Court of Federal Claims seeking compensation for alleged vaccine-related injuries.
According to statistics published by the Health Resources and Services Administration (HRSA), which administers the Vaccine Injury Compensation Program, the number of petitions filed in recent fiscal years includes:
FY 2016 – 1,120 petitions filed
FY 2017 – 1,243 petitions filed
FY 2018 – 1,238 petitions filed
FY 2019 – 1,282 petitions filed
FY 2020 – 1,192 petitions filed
FY 2021 – 2,057 petitions filed
FY 2022 – 1,029 petitions filed
FY 2023 – 1,167 petitions filed
FY 2024 – 1,185 petitions filed
FY 2025 – 1,300 petitions filed
FY 2026 – 330 petitions filed as of March 1, 2026
The vaccines most frequently involved in Vaccine Injury Compensation Program claims are influenza vaccines and Tdap vaccines. This is primarily because they are among the most widely administered vaccines in the United States, not because they are inherently unsafe.
Influenza vaccines alone are administered hundreds of millions of times each year as part of national public health efforts to prevent seasonal influenza epidemics. When vaccines are administered at such a large scale across the population, even extremely rare adverse reactions can generate a measurable number of claims within the compensation system.
Why Vaccine Injury Claims Are Hard to Win
Although the Vaccine Injury Compensation Program (VICP) provides a specialized forum for resolving vaccine injury claims, proving that a vaccine caused a particular medical condition can still be challenging. Many of the conditions alleged in vaccine injury litigation—particularly neurological and autoimmune disorders—can arise spontaneously or be triggered by multiple possible causes unrelated to vaccination. As a result, determining whether a vaccine actually caused the injury often requires extensive medical evidence, scientific literature, and expert testimony.
To obtain compensation in vaccine court, a petitioner must demonstrate that it is more likely than not that the vaccine caused the injury. This legal standard is known as preponderance of the evidence, which is lower than the burden of proof required in traditional civil litigation. Even so, petitioners must still present credible medical evidence supporting a causal relationship between the vaccination and the injury.
One reason vaccine injury claims can be difficult to prove is that many of the autoimmune and neurological conditions alleged in vaccine litigation are extremely rare diseases in their own right. Some of these conditions occur at rates of approximately one case per 100,000 individuals or fewer in the general population. When a medical condition is that rare, there are often no large epidemiological studies examining environmental triggers—including vaccines—because the condition itself occurs so infrequently.
The rarity of vaccine-related autoimmune injuries is also reflected in the overall mathematics of vaccination in the United States. Each year, approximately 200 to 225 million vaccine doses are administered nationwide across childhood and adult immunization programs. By comparison, the Vaccine Injury Compensation Program receives roughly 1,200 petitions per year. Even if every petition represented a valid vaccine injury—which is not the case—the incidence would still be extremely small. Based on this comparison, the potential rate of vaccine-related autoimmune injury would be approximately 0.0005 percent, making such events among the rarest adverse outcomes in modern medicine.
Government medical experts evaluating vaccine injury claims often look for epidemiological evidence showing that a vaccine increases the risk of a specific autoimmune disease. In many cases involving rare neurological or autoimmune conditions, that type of epidemiological evidence does not exist because the condition occurs so infrequently in the general population. As a result, petitioners frequently rely on medical theory, case-specific evidence, expert testimony, and scientific literature to explain the biological mechanism linking vaccination to the injury.
Finally, contested vaccine injury claims often require extensive litigation before the Office of Special Masters. When the government disputes causation, the case may proceed to expert reports, legal briefing, and sometimes trial. Trial calendars for vaccine injury cases can extend several years into the future due to the limited number of Special Masters currently assigned to hear cases. Many practitioners believe that at least four additional Special Masters would be necessary to address the current case inventory and provide more timely resolutions for injured individuals seeking compensation through the Vaccine Injury Compensation Program.
For these reasons, although the VICP was designed to provide a more accessible forum than traditional product liability litigation, vaccine injury claims—particularly those involving complex autoimmune or neurological disorders—can still be difficult to prove and may require significant time and expert analysis to resolve.
The Bottom Line
The Vaccine Injury Compensation Program represents a unique approach to resolving vaccine injury claims in the United States. It reflects Congress’s effort to balance two important public health goals: maintaining a stable vaccine supply while ensuring that individuals who experience rare vaccine-related injuries have access to meaningful compensation.
First, the VICP exists to provide compensation to the small percentage of individuals who suffer serious adverse reactions following vaccination. Although vaccines are overwhelmingly safe and remain one of the most effective tools in modern medicine, Congress recognized that when rare injuries occur, those individuals should not bear the financial burden alone.
Second, it is important to understand what the Vaccine Program does—and does not—do. Decisions within the VICP do not establish definitive scientific proof that a vaccine causes or does not cause a particular condition. Rather, the program evaluates whether the evidence in an individual case demonstrates that it is more likely than not that the vaccine caused the injury.
Third, the program is funded through a federal excise tax on each covered vaccine dose that is deposited into the Vaccine Injury Compensation Trust Fund. This structure ensures that vaccine manufacturers contribute to the compensation system rather than receiving liability protections without cost.
Fourth, the VICP provides a forum where injured individuals may pursue compensation under a more accessible evidentiary framework. Although civil lawsuits against pharmaceutical companies might appear attractive due to the size of potential verdicts, proving scientific causation in traditional civil courts is extraordinarily difficult. Civil courts apply stricter evidentiary rules and expert witness standards, including the Daubert standard, which can prevent expert testimony when scientific theories cannot be tested or conclusively validated. Vaccine court was designed to allow medically plausible theories of causation to be considered even when definitive scientific testing may not yet exist.
Finally, maintaining a robust compensation program that fairly and efficiently resolves vaccine injury claims fulfills the intent of the Vaccine Act. A system that recognizes and compensates legitimate injuries while supporting widespread vaccination helps preserve public confidence in both scientific institutions and national immunization programs.